Advanced Medicine

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

The remarkable story of gene therapy drug development during the 1990s and early 2000s.

Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

How can companies realistically incorporate patient-centric practices into cell and gene product development?

Can cell and gene therapy help bring an end to rare eye diseases?

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation